Peak6 Investments LLC Bio N Tech Se Put Options Transaction History

Peak6 Investments LLC

$37.5 Billion
Q2 2024

Put Options

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$80.36 - $102.87 $4.39 Million - $5.62 Million	54,600 Added 674.07%	62,700 $5.04 Million
Q1 2024 May 14, 2024	SELL	$88.96 - $112.35 $9.76 Million - $12.3 Million	-109,700 Reduced 93.12%	8,100 $747,000
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $1.8 Million - $2.23 Million	19,800 Added 20.2%	117,800 $12.4 Million
Q3 2023 Nov 13, 2023	SELL	$98.5 - $125.08 $1.87 Million - $2.38 Million	-19,000 Reduced 16.24%	98,000 $10.6 Million
Q2 2023 Aug 11, 2023	SELL	$102.58 - $129.66 $1.51 Million - $1.91 Million	-14,700 Reduced 11.16%	117,000 $12.6 Million
Q1 2023 May 12, 2023	SELL	$122.57 - $153.67 $16.2 Million - $20.3 Million	-131,800 Reduced 50.02%	131,700 $16.4 Million
Q4 2022 Feb 10, 2023	BUY	$118.43 - $186.05 $4.15 Million - $6.51 Million	35,000 Added 15.32%	263,500 $39.6 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $8.94 Million - $12.8 Million	-70,000 Reduced 23.45%	228,500 $30.8 Million
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $8.26 Million - $12.5 Million	-67,000 Reduced 18.33%	298,500 $44.5 Million
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $15.8 Million - $28.9 Million	-124,800 Reduced 25.45%	365,500 $62.3 Million
Q4 2021 Feb 11, 2022	SELL	$216.64 - $362.52 $1.45 Million - $2.43 Million	-6,700 Reduced 1.35%	490,300 $126 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $85.5 Million - $186 Million	415,400 Added 509.07%	497,000 $136 Million
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $5.9 Million - $12.6 Million	52,100 Added 176.61%	81,600 $18.3 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $2.53 Million - $3.53 Million	29,500 New	29,500 $3.22 Million

Others Institutions Holding BNTX

# of Institutions

328

Shares Held

40.6M

Call Options Held

845K

Put Options Held

1.23M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account